Human Umbilical Cord Mesenchymal Stem Cells-derived Exosomal lncRNA FAM99B Represses Hepatocellular Carcinoma Cell Malignancy
-
Published:2023-06-23
Issue:
Volume:
Page:
-
ISSN:1073-6085
-
Container-title:Molecular Biotechnology
-
language:en
-
Short-container-title:Mol Biotechnol
Author:
Xu Gang, Ban Kunfeng, Mu Haifeng, Wang BaochenORCID
Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,Bioengineering,Biotechnology
Reference34 articles.
1. Shimada, S., Mogushi, K., Akiyama, Y., Furuyama, T., Watanabe, S., Ogura, T., Ogawa, K., Ono, H., Mitsunori, Y., Ban, D., Kudo, A., Arii, S., Tanabe, M., Wands, J. R., & Tanaka, S. (2019). Comprehensive molecular and immunological characterization of hepatocellular carcinoma. EBioMedicine, 40, 457–470. 2. Li, Y., Chen, B., Yang, X., Zhang, C., Jiao, Y., Li, P., Liu, Y., Li, Z., Qiao, B., Bond Lau, W., Ma, X. L., & Du, J. (2019). S100a8/a9 signaling causes mitochondrial dysfunction and cardiomyocyte death in response to Ischemic/Reperfusion Injury. Circulation, 140, 751–764. 3. Liu, Y., Sun, L., Gao, F., Yang, X., Li, Y., Zhang, Q., Zhu, B., Niu, S., Huang, Y., Hu, Y., Feng, Y., Jiang, Y., & Wang, X. (2018). A new scoring model predicting macroscopic vascular invasion of early-intermediate hepatocellular carcinoma. Medicine (Baltimore).97,e13536. 4. Cheng, S., Chen, M., Cai, J., Sun, J., Guo, R., Bi, X., Lau, W. Y., & Wu, M. (2020). Chinese Expert Consensus on Multidisciplinary diagnosis and treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (2018 Edition). Liver Cancer, 9, 28–40. 5. Pan, W., Li, W., Zhao, J., Huang, Z., Zhao, J., Chen, S., Wang, C., Xue, Y., Huang, F., Fang, Q., Wang, J., Brand, D., & Zheng, S. G. (2019). lncRNA-PDPK2P promotes hepatocellular carcinoma progression through the PDK1/AKT/Caspase 3 pathway. Molecular Oncology, 13, 2246–2258.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|